BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26386744)

  • 1. TB meets COPD: An emerging global co-morbidity in human lung disease.
    O'Toole RF; Shukla SD; Walters EH
    Tuberculosis (Edinb); 2015 Dec; 95(6):659-663. PubMed ID: 26386744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD.
    Wu MF; Jian ZH; Huang JY; Jan CF; Nfor ON; Jhang KM; Ku WY; Ho CC; Lung CC; Pan HH; Wu MC; Liaw YP
    BMC Cancer; 2016 Oct; 16(1):778. PubMed ID: 27724847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nationwide population-based study of the risk of tuberculosis in different solid organ transplantations in Taiwan.
    Chen CH; Shu KH; Ho HC; Cheng SB; Lin CC; Wei HJ; Lin CH; Chang SN; Wu MJ
    Transplant Proc; 2014 May; 46(4):1032-5. PubMed ID: 24815120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of tuberculosis in COPD.
    Yakar HI; Gunen H; Pehlivan E; Aydogan S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():323-329. PubMed ID: 28176901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis: a disease without boundaries.
    Fogel N
    Tuberculosis (Edinb); 2015 Sep; 95(5):527-31. PubMed ID: 26198113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis and lung damage: from epidemiology to pathophysiology.
    Ravimohan S; Kornfeld H; Weissman D; Bisson GP
    Eur Respir Rev; 2018 Mar; 27(147):. PubMed ID: 29491034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophils in Tuberculosis-Associated Inflammation and Lung Pathology.
    Muefong CN; Sutherland JS
    Front Immunol; 2020; 11():962. PubMed ID: 32536917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in respiratory function impairment following the treatment of severe pulmonary tuberculosis - limitations for the underlying COPD detection.
    Radovic M; Ristic L; Ciric Z; Dinic-Radovic V; Stankovic I; Pejcic T; Rancic M; Bogdanovic D
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1307-16. PubMed ID: 27366058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The microbiome at the pulmonary alveolar niche and its role in Mycobacterium tuberculosis infection.
    Adami AJ; Cervantes JL
    Tuberculosis (Edinb); 2015 Dec; 95(6):651-658. PubMed ID: 26455529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of lung damage in tuberculosis: implications for chronic obstructive pulmonary disease.
    Kayongo A; Nyiro B; Siddharthan T; Kirenga B; Checkley W; Lutaakome Joloba M; Ellner J; Salgame P
    Front Cell Infect Microbiol; 2023; 13():1146571. PubMed ID: 37415827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell Carcinoma.
    Huang JY; Jian ZH; Ndi Nfor O; Jhang KM; Ku WY; Ko PC; Jan SR; Ho CC; Lung CC; Pan HH; Liang YC; Liaw YP
    PLoS One; 2015; 10(7):e0133367. PubMed ID: 26196516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of inhaled corticosteroids and the risk of tuberculosis.
    Lee CH; Kim K; Hyun MK; Jang EJ; Lee NR; Yim JJ
    Thorax; 2013 Dec; 68(12):1105-13. PubMed ID: 23749841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of microbiota in respiratory health and diseases, particularly in tuberculosis.
    Shah T; Shah Z; Baloch Z; Cui X
    Biomed Pharmacother; 2021 Nov; 143():112108. PubMed ID: 34560539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA
    Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronic obstructive pulmonary disease.
    Lee CH; Lee MC; Lin HH; Shu CC; Wang JY; Lee LN; Chao KM
    PLoS One; 2012; 7(5):e37978. PubMed ID: 22662259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Manipulation of the Lipid Mediator Metabolism as Adjunct Host-Directed Therapy in Tuberculosis.
    Nienaber A; Hayford FEA; Variava E; Martinson N; Malan L
    Front Immunol; 2021; 12():623941. PubMed ID: 33777003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of active tuberculosis following resumption of anti-TNF-α therapy in a patient with Crohn's disease.
    Masiá M; Martínez M; García-Sepulcre MF; Sáez J; Gutiérrez F
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):249-50. PubMed ID: 24429322
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathology of TB/COVID-19 Co-Infection: The phantom menace.
    Mousquer GT; Peres A; Fiegenbaum M
    Tuberculosis (Edinb); 2021 Jan; 126():102020. PubMed ID: 33246269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis as a three-act play: A new paradigm for the pathogenesis of pulmonary tuberculosis.
    Hunter RL
    Tuberculosis (Edinb); 2016 Mar; 97():8-17. PubMed ID: 26980490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.
    Horvath CN; Xing Z
    Adv Exp Med Biol; 2013; 783():267-78. PubMed ID: 23468114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.